SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-08 |
| Reported value | $526,407,169 |
| Positions | 13 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| PERSONALIS INC | PSNL | COM | $188,202,236 | 14,044,943 |
| MODERNA INC | MRNA | COM | $161,642,545 | 2,308,190 |
| KYMERA THERAPEUTICS INC | KYMR | COM | $88,544,161 | 772,165 |
| AKTIS ONCOLOGY INC | AKTS | COM | $30,710,162 | 952,844 |
| EIKON THERAPEUTICS INC | EIKN | COM | $21,749,991 | 1,666,666 |
| ENTRADA THERAPEUTICS INC | TRDA | COM | $12,804,692 | 1,739,768 |
| SUTRO BIOPHARMA INC | STRO | COM | $9,042,053 | 272,351 |
| ALECTOR INC | ALEC | COM | $7,126,896 | 3,545,719 |
| EVAXION BIOTECH A/S | EVAX | SPONSORED ADS | $3,763,791 | 1,214,126 |
| VIRIDIAN THERAPEUTICS INC | VRDN | COM | $1,716,015 | 93,414 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.